Minimally invasive parathyroid surgery, the Norman 20% rule: is it valid?

Area of Science:

• Endocrinology
• Surgical Oncology
• Nuclear Medicine

Background:

• Primary hyperparathyroidism often necessitates parathyroidectomy.
• Minimally invasive radioguided parathyroidectomy (MIRP) utilizes radioactivity for gland localization.
• The 20% rule is a proposed guideline for confirming abnormal parathyroid gland removal during MIRP.

Purpose of the Study:

• To independently evaluate the efficacy of the 20% rule in MIRP procedures.
• To assess the reliability of the 20% rule for abnormal parathyroid gland identification.
• To determine if the 20% rule can obviate the need for intraoperative parathyroid hormone assay or frozen section.

Main Methods:

• Retrospective analysis of 216 MIRP patients from the University of Louisville Parathyroid Database (1999-2007).
• Calculation of ex vivo parathyroid gland radioactivity relative to excision site/background radioactivity.
• Assessment of postoperative normocalcemia at 12-month follow-up.

Main Results:

• The average radioactivity ratio was 107% (range 14-388%).
• 99% of resected glands met the 20% rule threshold (radioactivity ≥20% of excision site).
• 98.5% of patients achieved normocalcemia at 12 months post-MIRP.

Conclusions:

• The 20% rule is a reliable method for confirming abnormal parathyroid gland removal during MIRP.
• Adherence to the 20% rule in MIRP allows successful localization and removal without intraoperative monitoring.
• The 20% rule supports efficient and effective surgical management of primary hyperparathyroidism.